Pemoline-associated fulminant liver failure: Testing the evidence for causation

199583 citationsReview

Authors

Matitiahu Berkovitch · Systems, Applications & Products in Data Processing (Canada)

Elena Pope · Systems, Applications & Products in Data Processing (Canada)

J. C. Phillips · Systems, Applications & Products in Data Processing (Canada)

Gideon Koren · Systems, Applications & Products in Data Processing (Canada)

Abstract

Because pemoline has been widely used in recent years, further studies are needed to better quantify this risk in children with attention deficit-hyperactivity disorder.

Topics & Keywords

Pharmaceutical studies and practices Pharmacological Effects and Toxicity Studies Drug Transport and Resistance Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Pharmacology & Therapeutics

Volume 57, Issue 6, pp. 696-698

DOI: 10.1016/0009-9236(95)90233-3

Field-Weighted Citation Impact: 20.24